HUMAHumacyte, Inc.
1.100USD+4.76%Mkt Cap: 245.33M USDP/E: Last update: 2026-05-26

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of ana…

Indicators:|

Key Statistics

Company
Market Cap245.33M USD
Enterprise Value244.42M USD
Revenue (TTM)2.02M USD
Gross Profit-7.66M USD
Net Income (TTM)-40.83M USD
Revenue/Share0.0120 USD
Last Price1.100 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees184
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-6.38
PEG
EV/EBITDA-2.32
EV/Revenue121.24
P/S112.33
P/B63.75
EPS (TTM)-0.63
EPS (Forward)-0.16
52W Range
0.547023% of range2.930
52W High2.930 USD
52W Low0.5470 USD
Profitability
Gross Margin-376.05%
Oper. Margin-5704.04%
EBITDA Margin0.00%
Profit Margin-2003.58%
ROE-1313.38%
ROA-35.09%
Growth
Revenue Growth-4.30%
Earnings Growth
Cash Flow & Leverage
Operating CF-105.04M USD
CapEx (TTM)884.00K USD
FCF Margin-3214.61%
FCF Yield-26.42%
Net Debt17.96M USD
Net Debt/EBITDA-0.17
Balance Sheet
Debt/Equity20.86
Current Ratio3.93
Quick Ratio3.02
Book Value/Sh0.0160 USD
Cash/Share0.2190 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)5.000 USD
Target Range1.000 USD25.00 USD
# Analysts7
Ownership
Shares Out.222.02M
Float190.86M
Insiders9.12%
Institutions26.96%
Short Interest
Short Ratio8.5d
Short % Float20.28%
Short % Out.20.13%
Shares Short44.70M
Short (prev mo.)42.22M
Technical
SMA 500.8295 (+32.6%)
SMA 2001.243 (-11.5%)
Beta2.31
S&P 52W Chg28.31%
Avg Vol (30d)5.93M
Avg Vol (10d)8.39M
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)